According to several previous reports, IL-25 protects against renal injury in individuals with drug-induced kidney disease by inducing M2 macrophages or eliciting group 2 innate lymphoid cells and multipotent progenitor type 2 cells [19–21]. The gene discussed is IL25; the disease is kidney disorder.